Ingevity (NGVT) urged shareholders to vote in favor of all of its board nominees Thursday in a letter accompanying its definitive proxy statement ahead of its annual meeting on April 30, where a proxy fight may take place with activist investor Vision One Fund.
The company said it has made "meaningful efforts to reach a constructive resolution and avoid a proxy fight" with Vision One, which it said is seeking the election of two nominees.
The South Carolina specialty chemicals company said the activist investor's two nominees have never served as company directors or senior executives of a publicly-traded firm and have no industry experience.
Vision One did not immediately reply to MT Newswires' request for comment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.